ZYNERBA PHARMACEUTICALS, INC. Current Liabilities
ZYNERBA PHARMACEUTICALS, INC. had Current Liabilities of $11.46 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2023-08-14
- 2023-06-30: Liabilities, Current $11.46M.
- 2023-03-31: Liabilities, Current $9.61M.
- 2022-12-31: Liabilities, Current $9.17M.
- 2022-09-30: Liabilities, Current $9.43M.
| Period end | Liabilities, Current |
|---|---|
| 2023-06-30 | $11.46M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $9.61M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $9.17M 10-Q · filed 2023-08-14 |
| 2022-09-30 | $9.43M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $9.53M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $8.92M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $9.90M 10-K · filed 2023-03-28 |
| 2021-09-30 | $10.90M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $10.03M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $12.57M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $13.91M 10-K · filed 2022-03-01 |
| 2020-09-30 | $10.57M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $13.06M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $10.26M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $12.06M 10-K · filed 2021-03-10 |
| 2019-09-30 | $9.30M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $9.99M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $7.47M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $9.73M 10-K · filed 2020-03-10 |
| 2018-09-30 | $9.14M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $11.29M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $8.91M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $7.44M 10-K · filed 2019-03-11 |
| 2017-09-30 | $8.43M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $7.86M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $6.94M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $6.97M 10-K · filed 2018-03-12 |
| 2016-09-30 | $4.95M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $5.03M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $2.91M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $3.94M 10-K · filed 2017-03-27 |
| 2015-09-30 | $2.71M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $4.13M 10-Q · filed 2015-08-27 |
| 2014-12-31 | $3.15M 10-K · filed 2016-03-14 |